Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Audrey Gerard, an Associate Professor of Immune Cell Dynamics and Principal Investigator at the Kennedy Institute of Rheumatology, is working to understand how the immune response interacts with and shapes tumours.

Audrey Gérard

Audrey’s research, funded by the Oxford Cancer Immuno-Oncology Network (OCION), is examining the relationship between the immune response triggered in cancer and atherosclerosis.

‘Anti-cancer treatments which aim at awakening immune responses, called checkpoint blockade, further increase the risk of developing cardiovascular diseases, highlighting the role of our immune system in both cancer and atherosclerosis,’ explains Audrey in an interview with OCION. The long-term goal is to identify ways to target the immune system to induce anti-cancer responses without increasing the likelihood of developing cardiovascular diseases.

Audrey recently talked to OCION about her work and the future of her research. You can read the full interview on the Oxford Cancer website.